Clinical Trial Update: Comparison of Vaccination Routes: Subcutaneous Versus Intramuscular Application of FSME-Immun® [Phase 4]

View source ↗

Summary

A Phase 4 study comparing subcutaneous versus intramuscular administration of FSME-Immun for Tick-borne encephalitis; results were posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tick-borne Encephalitis

Drugs mentioned

• FSME-IMMUN (Tick-borne encephalitis vaccine (inactivated))

Snippet

Sponsor: Medical University of Vienna | Conditions: Vaccine Efficacy | Phase 4 | Status: COMPLETED | Results posted: 2018-05-18